337 related articles for article (PubMed ID: 17397031)
1. Cutaneous phenotype and MC1R variants as modifying factors for the development of melanoma in CDKN2A G101W mutation carriers from 4 countries.
Goldstein AM; Chaudru V; Ghiorzo P; Badenas C; Malvehy J; Pastorino L; Laud K; Hulley B; Avril MF; Puig-Butille JA; Miniere A; Marti R; Chompret A; Cuellar F; Kolm I; Mila M; Tucker MA; Demenais F; Bianchi-Scarra G; Puig S; de-Paillerets BB
Int J Cancer; 2007 Aug; 121(4):825-31. PubMed ID: 17397031
[TBL] [Abstract][Full Text] [Related]
2. Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.
Demenais F; Mohamdi H; Chaudru V; Goldstein AM; Newton Bishop JA; Bishop DT; Kanetsky PA; Hayward NK; Gillanders E; Elder DE; Avril MF; Azizi E; van Belle P; Bergman W; Bianchi-Scarrà G; Bressac-de Paillerets B; Calista D; Carrera C; Hansson J; Harland M; Hogg D; Höiom V; Holland EA; Ingvar C; Landi MT; Lang JM; Mackie RM; Mann GJ; Ming ME; Njauw CJ; Olsson H; Palmer J; Pastorino L; Puig S; Randerson-Moor J; Stark M; Tsao H; Tucker MA; van der Velden P; Yang XR; Gruis N;
J Natl Cancer Inst; 2010 Oct; 102(20):1568-83. PubMed ID: 20876876
[TBL] [Abstract][Full Text] [Related]
3. Influence of loss of function MC1R variants in genetic susceptibility of familial melanoma in Spain.
de Torre C; Garcia-Casado Z; Martínez-Escribano JA; Botella-Estrada R; Bañuls J; Oliver V; Mercader P; Azaña JM; Frias J; Nagore E
Melanoma Res; 2010 Aug; 20(4):342-8. PubMed ID: 20539244
[TBL] [Abstract][Full Text] [Related]
4. Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations.
Goldstein AM; Landi MT; Tsang S; Fraser MC; Munroe DJ; Tucker MA
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2208-12. PubMed ID: 16172233
[TBL] [Abstract][Full Text] [Related]
5. CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma.
Pastorino L; Bonelli L; Ghiorzo P; Queirolo P; Battistuzzi L; Balleari E; Nasti S; Gargiulo S; Gliori S; Savoia P; Abate Osella S; Bernengo MG; Bianchi Scarrà G
Pigment Cell Melanoma Res; 2008 Dec; 21(6):700-9. PubMed ID: 18983535
[TBL] [Abstract][Full Text] [Related]
6. MC1R variation and melanoma risk in relation to host/clinical and environmental factors in CDKN2A positive and negative melanoma patients.
Ghiorzo P; Bonelli L; Pastorino L; Bruno W; Barile M; Andreotti V; Nasti S; Battistuzzi L; Grosso M; Bianchi-Scarrà G; Queirolo P
Exp Dermatol; 2012 Sep; 21(9):718-20. PubMed ID: 22804906
[TBL] [Abstract][Full Text] [Related]
7. Melanocortin-1 receptor (MC1R) gene variants and dysplastic nevi modify penetrance of CDKN2A mutations in French melanoma-prone pedigrees.
Chaudru V; Laud K; Avril MF; Minière A; Chompret A; Bressac-de Paillerets B; Demenais F
Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2384-90. PubMed ID: 16214921
[TBL] [Abstract][Full Text] [Related]
8. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
Landi MT; Kanetsky PA; Tsang S; Gold B; Munroe D; Rebbeck T; Swoyer J; Ter-Minassian M; Hedayati M; Grossman L; Goldstein AM; Calista D; Pfeiffer RM
J Natl Cancer Inst; 2005 Jul; 97(13):998-1007. PubMed ID: 15998953
[TBL] [Abstract][Full Text] [Related]
9. CDKN2A and MC1R variants influence dermoscopic and confocal features of benign melanocytic lesions in multiple melanoma patients.
Bassoli S; Maurichi A; Rodolfo M; Casari A; Frigerio S; Pupelli G; Farnetani F; Pelosi G; Santinami M; Pellacani G
Exp Dermatol; 2013 Jun; 22(6):411-6. PubMed ID: 23711066
[TBL] [Abstract][Full Text] [Related]
10. Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study.
Fargnoli MC; Altobelli E; Keller G; Chimenti S; Höfler H; Peris K
Melanoma Res; 2006 Apr; 16(2):175-82. PubMed ID: 16567973
[TBL] [Abstract][Full Text] [Related]
11. MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis.
Fargnoli MC; Gandini S; Peris K; Maisonneuve P; Raimondi S
Eur J Cancer; 2010 May; 46(8):1413-20. PubMed ID: 20189796
[TBL] [Abstract][Full Text] [Related]
12. Dermoscopic features of melanomas associated with MC1R variants in Spanish CDKN2A mutation carriers.
Cuéllar F; Puig S; Kolm I; Puig-Butille J; Zaballos P; Martí-Laborda R; Badenas C; Malvehy J
Br J Dermatol; 2009 Jan; 160(1):48-53. PubMed ID: 18795926
[TBL] [Abstract][Full Text] [Related]
13. Main pigmentary features and melanocortin 1 receptor (MC1R) gene polymorphisms in the population of the Canary Islands.
de-Misa RF; Pérez-Méndez LI; Hernández-Jiménez JG; Rodríguez Mdel C; Vilar MC; Suárez J; Claveríe-Martín F
Int J Dermatol; 2008 Aug; 47(8):806-11. PubMed ID: 18717860
[TBL] [Abstract][Full Text] [Related]
14. Swedish CDKN2A mutation carriers do not present the atypical mole syndrome phenotype.
Nielsen K; Harbst K; Måsbäck A; Jönsson G; Borg A; Olsson H; Ingvar C
Melanoma Res; 2010 Aug; 20(4):266-72. PubMed ID: 20526219
[TBL] [Abstract][Full Text] [Related]
15. The contribution of melanocortin 1 receptor gene polymorphisms and the agouti signalling protein gene 8818A>G polymorphism to cutaneous melanoma and basal cell carcinoma in a Polish population.
Brudnik U; Branicki W; Wojas-Pelc A; Kanas P
Exp Dermatol; 2009 Feb; 18(2):167-74. PubMed ID: 18637131
[TBL] [Abstract][Full Text] [Related]
16. Sporadic melanoma in South-Eastern Italy: the impact of melanocortin 1 receptor (MC1R) polymorphism analysis in low-risk people and report of three novel variants.
Guida S; Bartolomeo N; Zanna PT; Grieco C; Maida I; De Summa S; Tommasi S; Guida M; Azzariti A; Foti C; Filotico R; Guida G
Arch Dermatol Res; 2015 Aug; 307(6):495-503. PubMed ID: 25736238
[TBL] [Abstract][Full Text] [Related]
17. High naevus count and MC1R red hair alleles contribute synergistically to increased melanoma risk.
Duffy DL; Lee KJ; Jagirdar K; Pflugfelder A; Stark MS; McMeniman EK; Soyer HP; Sturm RA
Br J Dermatol; 2019 Nov; 181(5):1009-1016. PubMed ID: 30820946
[TBL] [Abstract][Full Text] [Related]
18. p53 codon 72 Pro homozygosity increases the risk of cutaneous melanoma in individuals with dark skin complexion and among noncarriers of melanocortin 1 receptor red hair variants.
Stefanaki I; Stratigos AJ; Dimisianos G; Nikolaou V; Papadopoulos O; Polydorou D; Gogas H; Tsoutsos D; Panagiotou P; Kanavakis E; Antoniou C; Katsambas AD
Br J Dermatol; 2007 Feb; 156(2):357-62. PubMed ID: 17223878
[TBL] [Abstract][Full Text] [Related]
19. Assessment of polymorphic variants in the melanocortin-1 receptor gene with cutaneous pigmentation using an evolutionary approach.
Kanetsky PA; Ge F; Najarian D; Swoyer J; Panossian S; Schuchter L; Holmes R; Guerry D; Rebbeck TR
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):808-19. PubMed ID: 15159314
[TBL] [Abstract][Full Text] [Related]
20. Melanocortin receptor 1 variants and melanoma risk: a study of 2 European populations.
Scherer D; Nagore E; Bermejo JL; Figl A; Botella-Estrada R; Thirumaran RK; Angelini S; Hemminki K; Schadendorf D; Kumar R
Int J Cancer; 2009 Oct; 125(8):1868-75. PubMed ID: 19585506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
